No liability to heirs for outstanding debt related to treatment with investigational drug, biological product, or device.

S.C. Code Ann. § 44-137-30
in effect
Sign in to generate a plain English summaryAsk Belisarius Agent
If an eligible patient dies while being treated with an investigational drug, biological product, or device, the eligible patient's heirs are not liable for any outstanding debt related to the treatment, including any costs attributed to lack of insurance coverage for the treatment.
Source: Open US Law by Vaquill AI (CC BY 4.0)URL: https://www.scstatehouse.gov/code/t44c137.phpFetched: 10/17/2026
S.C. Code Ann. § 44-137-30 — No liability to heirs for outstanding debt related to treatment with investigational drug, biological product, or device | Code of Laws of South Carolina (Aug. 2026 snapshot) | Corpus